This demonstrates that TRPC6 inactivation is an aggravating feature for hypoglycemia-induced cognitive impairment, and a protective feature in cases of its activation, making TRPC6 a potential therapeutic target [120,121]. The gene discussed is TRPC6; the disease is Cognitive impairment.